Ronald N. Jones

1.9k total citations · 1 hit paper
38 papers, 1.4k citations indexed

About

Ronald N. Jones is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Ronald N. Jones has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Medicine, 23 papers in Pharmacology and 14 papers in Epidemiology. Recurrent topics in Ronald N. Jones's work include Antibiotic Resistance in Bacteria (29 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers) and Pneumonia and Respiratory Infections (10 papers). Ronald N. Jones is often cited by papers focused on Antibiotic Resistance in Bacteria (29 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers) and Pneumonia and Respiratory Infections (10 papers). Ronald N. Jones collaborates with scholars based in United States, Switzerland and Brazil. Ronald N. Jones's co-authors include Arthur L. Barry, Michael A. Pfaller, Meridith E. Erwin, Harald Seifert, Hilmar Wisplinghoff, Richard P. Wenzel, Michael B. Edmond, Antônio Carlos Campos Pignatari, Hélio S. Sader and Mary S. Barrett and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and Drugs.

In The Last Decade

Ronald N. Jones

38 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microbial Etiologies of Hospital‐Acquired Bacterial Pneumonia and Ventilator‐Associated Bacterial Pneumonia

2010 528 citations Ronald N. Jones Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ronald N. Jones United States	17	725	550	455	267	262	38	1.4k
M. Roussel‐Delvallez France	14	606 0.8×	713 1.3×	311 0.7×	333 1.2×	271 1.0×	43	1.6k
Pamela Kibsey Canada	18	435 0.6×	741 1.3×	275 0.6×	179 0.7×	386 1.5×	37	1.4k
Jacques Tankovic France	26	719 1.0×	653 1.2×	478 1.1×	468 1.8×	522 2.0×	57	2.1k
Noriel Mariano United States	19	780 1.1×	401 0.7×	440 1.0×	148 0.6×	179 0.7×	31	1.1k
Mark E. Jones United States	13	743 1.0×	402 0.7×	210 0.5×	176 0.7×	170 0.6×	14	1.2k
Sandra Willey United States	13	392 0.5×	440 0.8×	252 0.6×	174 0.7×	686 2.6×	13	1.3k
L. Stratchounski Russia	16	609 0.8×	536 1.0×	187 0.4×	120 0.4×	141 0.5×	25	1.2k
Jean-Claude Péchère Switzerland	20	1.1k 1.5×	403 0.7×	451 1.0×	913 3.4×	216 0.8×	35	2.1k
C J Soussy France	8	591 0.8×	326 0.6×	360 0.8×	189 0.7×	213 0.8×	14	1.2k
Deborah C. Draghi United States	22	742 1.0×	513 0.9×	447 1.0×	362 1.4×	783 3.0×	33	1.9k

Countries citing papers authored by Ronald N. Jones

Since Specialization

Citations

This map shows the geographic impact of Ronald N. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald N. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald N. Jones more than expected).

Fields of papers citing papers by Ronald N. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald N. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald N. Jones. The network helps show where Ronald N. Jones may publish in the future.

Co-authorship network of co-authors of Ronald N. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald N. Jones. A scholar is included among the top collaborators of Ronald N. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald N. Jones. Ronald N. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jones, Ronald N.. (2010). Microbial Etiologies of Hospital‐Acquired Bacterial Pneumonia and Ventilator‐Associated Bacterial Pneumonia. Clinical Infectious Diseases. 51(S1). S81–S87. 528 indexed citations breakdown →

Wisplinghoff, Hilmar, Michael B. Edmond, Michael A. Pfaller, et al.. (2000). Nosocomial Bloodstream Infections Caused by Acinetobacter Species in United States Hospitals: Clinical Features, Molecular Epidemiology, and Antimicrobial Susceptibility. Clinical Infectious Diseases. 31(3). 690–697. 181 indexed citations

Jones, Ronald N., et al.. (2000). Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Diagnostic Microbiology and Infectious Disease. 37(2). 115–125. 51 indexed citations

Marco, Francesc, Douglas J. Biedenbach, & Ronald N. Jones. (1997). Anti-Legionella activity of trovafloxacin compared with seven other antimicrobial agents including an intermethod evaluation. Diagnostic Microbiology and Infectious Disease. 29(1). 55–57. 5 indexed citations

Howard, Wanita J., et al.. (1997). Accuracy of the Vitek system for antimicrobial susceptibility testing Enterobacteriaceae bloodstream infection isolates: use of “direct” inoculation from Bactec 9240 blood culture bottles. Diagnostic Microbiology and Infectious Disease. 28(2). 101–104. 19 indexed citations

Jones, Ronald N., Martin Cormican, & Audrey Wanger. (1996). Clindamycin resistance among erythromycin-resistant Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease. 25(4). 201–204. 12 indexed citations

Cormican, Martin, Steven A. Marshall, & Ronald N. Jones. (1995). Preliminary interpretive criteria for disk diffusion susceptibility testing of SCH 27899, a compound in the everninomicin class of antimicrobial agents. Diagnostic Microbiology and Infectious Disease. 23(4). 157–160. 5 indexed citations

Houston, A. & Ronald N. Jones. (1994). Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin. Diagnostic Microbiology and Infectious Disease. 18(1). 57–59. 16 indexed citations

Sader, Hélio S., et al.. (1994). Pulsed-field gel electrophoresis of restriction-digested genomic DNA and antimicrobial susceptibility of Xanthomonas maltophilia strains from Brazil, Switzerland and the USA. Journal of Antimicrobial Chemotherapy. 33(3). 615–618. 17 indexed citations

10.

Erwin, Meridith E., et al.. (1994). Cefquinome (HR 111V) in vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals. Diagnostic Microbiology and Infectious Disease. 20(1). 49–55. 46 indexed citations

11.

Jones, Ronald N., David M. Johnson, & Meridith E. Erwin. (1994). Interpretive criteria for DU-6859a disk diffusion tests using 5-μg disks. Diagnostic Microbiology and Infectious Disease. 18(2). 125–127. 4 indexed citations

12.

Marshall, Steven A., Ronald N. Jones, Patrick R. Murray, et al.. (1993). In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates. Journal of Antimicrobial Chemotherapy. 32(6). 877–884. 12 indexed citations

13.

Hoban, Daryl J., Ronald N. Jones, Nobuhisa Yamane, et al.. (1993). In vitro activity of three carbapenem antibiotics comparative studies with biapenem (L-627), imipenem, and meropenem against aerobic pathogens isolated worldwide. Diagnostic Microbiology and Infectious Disease. 17(4). 299–305. 32 indexed citations

14.

Sader, Hélio S., Antônio Carlos Campos Pignatari, Ivani Lúcia Leme, et al.. (1993). Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit. Diagnostic Microbiology and Infectious Disease. 17(1). 13–18. 105 indexed citations

15.

Jones, Ronald N., et al.. (1991). In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). Diagnostic Microbiology and Infectious Disease. 14(5). 425–434. 30 indexed citations

16.

Jones, Ronald N.. (1991). Antimicrobial activity and spectrum of ceftibuten (7432-S, SCH 39720) a review of United States and canadian results. Diagnostic Microbiology and Infectious Disease. 14(1). 37–43. 10 indexed citations

17.

Jones, Ronald N. & Arthur L. Barry. (1989). In vitro activity of Ro 23-9424, ceftazidime, and eight other newer beta-lactams against 100 Gram-positive blood culture isolates. Diagnostic Microbiology and Infectious Disease. 12(2). 143–147. 6 indexed citations

18.

Jones, Ronald N. & Arthur L. Barry. (1989). In vitro evaluation of ramoplanin (A16686 or MDL62198): A new depsipeptide complex for potential topical use. Diagnostic Microbiology and Infectious Disease. 12(3). 279–282. 31 indexed citations

19.

Jones, Ronald N., Kenneth E. Aldridge, Arthur L. Barry, et al.. (1988). Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing. Diagnostic Microbiology and Infectious Disease. 10(4). 221–240. 26 indexed citations

20.

Fuchs, Peter, Ronald N. Jones, & Arthur L. Barry. (1987). Effect of β-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic β-lactamase producing bacteria. Diagnostic Microbiology and Infectious Disease. 8(1). 61–65. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact